Filana Therapeutics, Inc. Common Stock, Value, Issued
Filana Therapeutics, Inc. (FLNA) had Common Stock, Value, Issued of $48.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-05-07
- 2026-03-31: Common Stock, Value, Issued $48.00K.
- 2025-12-31: Common Stock, Value, Issued $48.00K.
- 2025-09-30: Common Stock, Value, Issued $48.00K.
- 2025-06-30: Common Stock, Value, Issued $48.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-03-31 | $48.00K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $48.00K 10-Q · filed 2026-05-07 | |
| 2025-09-30 | $48.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $48.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $48.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $48.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $48.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $48.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $43.00K 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $42.00K 10-K · filed 2025-03-03 | |
| 2023-09-30 | $42.00K 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $42.00K 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $42.00K 10-Q · filed 2023-05-01 | |
| 2022-12-31 | $42.00K 10-K · filed 2024-02-28 | |
| 2022-09-30 | $40.00K 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $40.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $40.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $40.00K 10-K · filed 2023-02-28 | |
| 2021-09-30 | $40.00K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $40.00K 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $40.00K 10-Q · filed 2021-04-29 | |
| 2020-12-31 | $35.00K 10-K · filed 2022-03-01 | |
| 2020-09-30 | $26.00K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $25.00K 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $25.00K 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $22.00K 10-K · filed 2021-03-23 | |
| 2019-09-30 | $17.00K 10-Q · filed 2019-10-29 | |
| 2019-06-30 | $17.00K 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $17.00K 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $17.00K 10-K · filed 2020-03-26 | |
| 2018-09-30 | $17.00K 10-Q · filed 2018-10-30 | |
| 2018-06-30 | $7.00K 10-Q · filed 2018-07-26 | |
| 2018-03-31 | $7.00K 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $7.00K 10-K · filed 2019-03-29 | |
| 2017-09-30 | $7.00K 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $7.00K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $46.00K 10-Q · filed 2017-04-26 | |
| 2016-12-31 | $7.00K 10-K · filed 2018-02-06 | $46.00K 10-K · filed 2017-03-07 |
| 2016-09-30 | $46.00K 10-Q · filed 2016-10-26 | |
| 2016-06-30 | $46.00K 10-Q · filed 2016-07-19 | |
| 2016-03-31 | $46.00K 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $46.00K 10-K · filed 2017-03-07 | |
| 2015-09-30 | $46.00K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $46.00K 10-Q · filed 2015-07-23 | |
| 2015-03-31 | $46.00K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $46.00K 10-K · filed 2016-03-03 | |
| 2014-09-30 | $45.00K 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $45.00K 10-Q · filed 2014-08-06 | |
| 2014-03-31 | $45.00K 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $45.00K 10-K · filed 2015-02-18 | |
| 2013-09-30 | $45.00K 10-Q · filed 2013-11-01 | |
| 2013-06-30 | $45.00K 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $45.00K 10-Q · filed 2013-04-24 | |
| 2012-12-31 | $45.00K 10-K · filed 2014-02-05 | |
| 2012-09-30 | $45.00K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $45.00K 10-Q · filed 2012-08-02 | |
| 2012-03-31 | $45.00K 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $45.00K 10-K · filed 2013-02-08 | |
| 2011-09-30 | $45.00K 10-Q · filed 2011-11-03 | |
| 2011-06-30 | $45.00K 10-Q · filed 2011-08-04 | |
| 2010-12-31 | $43.00K 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |